玻璃体内注射贝伐单抗（阿瓦斯汀）治疗新生血管性青光眼眼前段新生血管的短期疗效 - Suppr

Suppr

超能文献

Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.

作者信息

Silva Paula Jayter, Jorge Rodrigo, Alves Costa Rogério, Rodrigues Maria de Lourdes V, Scott Ingrid U

出版信息

Acta Ophthalmol Scand. 2006 Aug;84(4):556-7. doi: 10.1111/j.1600-0420.2006.00731.x.

DOI:10.1111/j.1600-0420.2006.00731.x

PMID:16879583

Abstract

摘要

相似文献

Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.

Acta Ophthalmol Scand. 2006 Aug;84(4):556-7. doi: 10.1111/j.1600-0420.2006.00731.x.

Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.

Acta Ophthalmol. 2008 Sep;86(6):698-700. doi: 10.1111/j.1600-0420.2007.01106.x.

Regression of neovascular iris vessels by intravitreal injection of bevacizumab.

Retina. 2006 Sep;26(7):839-41. doi: 10.1097/01.iae.0000230425.31296.3b.

Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.

Am J Ophthalmol. 2010 Jun;149(6):964-972.e1. doi: 10.1016/j.ajo.2010.01.008. Epub 2010 Apr 9.

Intravitreal bevacizumab in a patient with neovascular glaucoma.

Ophthalmic Surg Lasers Imaging. 2006 Mar-Apr;37(2):144-6.

Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab.

Adv Ther. 2009 Feb;26(2):208-16. doi: 10.1007/s12325-009-0001-1. Epub 2009 Feb 20.

Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.

J Glaucoma. 2007 Aug;16(5):437-9. doi: 10.1097/IJG.0b013e3180457c47.

Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.

Ophthalmology. 2008 Sep;115(9):1571-80, 1580.e1-3. doi: 10.1016/j.ophtha.2008.02.026. Epub 2008 Apr 28.

[Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].

J Fr Ophtalmol. 2009 Nov;32(9):652-63. doi: 10.1016/j.jfo.2009.10.001. Epub 2009 Nov 4.

Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy.

Acta Ophthalmol. 2009 Nov;87(7):736-40. doi: 10.1111/j.1755-3768.2008.01353.x. Epub 2008 Sep 18.

引用本文的文献

Surgical Treatment of Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy in Japanese Patients without the Use of Glaucoma Drainage Devices.

J Clin Med. 2024 May 31;13(11):3252. doi: 10.3390/jcm13113252.

Central retinal thickness changes and risk of neovascular glaucoma after intravitreal bevacizumab injection in patients with central retinal vein occlusion.

Sci Rep. 2022 Feb 8;12(1):2051. doi: 10.1038/s41598-022-06121-x.

Neovascular Glaucoma Progress and Impact of Therapeutic Intervention in Saudi Arabia.

Cureus. 2021 Sep 3;13(9):e17696. doi: 10.7759/cureus.17696. eCollection 2021 Sep.

Anti-vascular endothelial growth factor for neovascular glaucoma.

Cochrane Database Syst Rev. 2020 Feb 6;2(2):CD007920. doi: 10.1002/14651858.CD007920.pub3.

What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study.

BMC Ophthalmol. 2019 Jun 11;19(1):128. doi: 10.1186/s12886-019-1138-6.

Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab.

Clin Ophthalmol. 2018 Dec 19;13:27-31. doi: 10.2147/OPTH.S182420. eCollection 2019.

Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience.

Clin Ophthalmol. 2017 Aug 7;11:1417-1422. doi: 10.2147/OPTH.S137470. eCollection 2017.

Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy.

Medicine (Baltimore). 2017 Mar;96(10):e6263. doi: 10.1097/MD.0000000000006263.

Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.

Eye (Lond). 2016 Mar;30(3):463-72. doi: 10.1038/eye.2015.259. Epub 2015 Dec 18.

The effect of intravitreal bevacizumab injection before Ahmed valve implantation in patients with neovascular glaucoma.

Int Ophthalmol. 2014 Aug;34(4):793-9. doi: 10.1007/s10792-013-9875-7. Epub 2013 Nov 2.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.

作者信息

Silva Paula Jayter, Jorge Rodrigo, Alves Costa Rogério, Rodrigues Maria de Lourdes V, Scott Ingrid U

出版信息

Acta Ophthalmol Scand. 2006 Aug;84(4):556-7. doi: 10.1111/j.1600-0420.2006.00731.x.

DOI:10.1111/j.1600-0420.2006.00731.x

PMID:16879583

Abstract

摘要

相似文献

Short-term results of intravitreal bevacizumab (Avastin) on anterior segment neovascularization in neovascular glaucoma.

Acta Ophthalmol Scand. 2006 Aug;84(4):556-7. doi: 10.1111/j.1600-0420.2006.00731.x.

Intravitreal and intracameral bevacizumab to treat neovascular complications of retinopathy of prematurity.

Acta Ophthalmol. 2008 Sep;86(6):698-700. doi: 10.1111/j.1600-0420.2007.01106.x.

Regression of neovascular iris vessels by intravitreal injection of bevacizumab.

Retina. 2006 Sep;26(7):839-41. doi: 10.1097/01.iae.0000230425.31296.3b.

Clinical factors related to recurrence of anterior segment neovascularization after treatment including intravitreal bevacizumab.

Am J Ophthalmol. 2010 Jun;149(6):964-972.e1. doi: 10.1016/j.ajo.2010.01.008. Epub 2010 Apr 9.

Intravitreal bevacizumab in a patient with neovascular glaucoma.

Ophthalmic Surg Lasers Imaging. 2006 Mar-Apr;37(2):144-6.

Clinical outcomes of patients with anterior segment neovascularization treated with or without intraocular bevacizumab.

Adv Ther. 2009 Feb;26(2):208-16. doi: 10.1007/s12325-009-0001-1. Epub 2009 Feb 20.

Intravitreal bevacizumab (Avastin) injection for neovascular glaucoma.

J Glaucoma. 2007 Aug;16(5):437-9. doi: 10.1097/IJG.0b013e3180457c47.

Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases.

Ophthalmology. 2008 Sep;115(9):1571-80, 1580.e1-3. doi: 10.1016/j.ophtha.2008.02.026. Epub 2008 Apr 28.

[Intravitreal bevacizumab for treatment of neovascular glaucoma. Report of 20 cases].

J Fr Ophtalmol. 2009 Nov;32(9):652-63. doi: 10.1016/j.jfo.2009.10.001. Epub 2009 Nov 4.

Analysis of the clinical efficacy of intravitreal bevacizumab in the treatment of iris neovascularization caused by proliferative diabetic retinopathy.

Acta Ophthalmol. 2009 Nov;87(7):736-40. doi: 10.1111/j.1755-3768.2008.01353.x. Epub 2008 Sep 18.

引用本文的文献

Surgical Treatment of Neovascular Glaucoma Secondary to Proliferative Diabetic Retinopathy in Japanese Patients without the Use of Glaucoma Drainage Devices.

J Clin Med. 2024 May 31;13(11):3252. doi: 10.3390/jcm13113252.

Central retinal thickness changes and risk of neovascular glaucoma after intravitreal bevacizumab injection in patients with central retinal vein occlusion.

Sci Rep. 2022 Feb 8;12(1):2051. doi: 10.1038/s41598-022-06121-x.

Neovascular Glaucoma Progress and Impact of Therapeutic Intervention in Saudi Arabia.

Cureus. 2021 Sep 3;13(9):e17696. doi: 10.7759/cureus.17696. eCollection 2021 Sep.

Anti-vascular endothelial growth factor for neovascular glaucoma.

Cochrane Database Syst Rev. 2020 Feb 6;2(2):CD007920. doi: 10.1002/14651858.CD007920.pub3.

What is the impact of intravitreal injection of conbercept on neovascular glaucoma patients: a prospective, interventional case series study.

BMC Ophthalmol. 2019 Jun 11;19(1):128. doi: 10.1186/s12886-019-1138-6.

Timing of neovascular regression in eyes with high-risk proliferative diabetic retinopathy without macular edema treated initially with intravitreous bevacizumab.

Clin Ophthalmol. 2018 Dec 19;13:27-31. doi: 10.2147/OPTH.S182420. eCollection 2019.

Glaucoma drainage device implantation with adjunctive intravitreal bevacizumab in neovascular glaucoma: 3-year experience.

Clin Ophthalmol. 2017 Aug 7;11:1417-1422. doi: 10.2147/OPTH.S137470. eCollection 2017.

Neovascular glaucoma after vitrectomy in patients with proliferative diabetic retinopathy.

Medicine (Baltimore). 2017 Mar;96(10):e6263. doi: 10.1097/MD.0000000000006263.

Long-term outcomes of neovascular glaucoma treated with and without intravitreal bevacizumab.

Eye (Lond). 2016 Mar;30(3):463-72. doi: 10.1038/eye.2015.259. Epub 2015 Dec 18.

The effect of intravitreal bevacizumab injection before Ahmed valve implantation in patients with neovascular glaucoma.

Int Ophthalmol. 2014 Aug;34(4):793-9. doi: 10.1007/s10792-013-9875-7. Epub 2013 Nov 2.